ABBV

AbbVie Inc.

Healthcare
215.43 +2.44 +1.15% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 380.62B
EV —
Shares Out 1.77B
Revenue (ttm) 62.82B
Net Income 3.63B
Beta —
P/E 104.90
Forward P/E —
EPS (ttm) $2.03
P/S 6.07
P/B -57.29
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 2.66%
ROE -107.01%
ROIC 14.11%
Gross Margin —
Oper. Margin 24.41%
Profit Margin 5.79%
Debt/Eq -10.95
LT Debt/Eq 111.5%
Quick Ratio —
Current Ratio 0.80
Book/sh -3.76
Cash/sh 5.31
Div Yield 3.13%
Div TTM $6.74
Payout Ratio 332.02%
SMA20 2.23%
SMA50 3.29%
SMA200 -1.94%
Volume 5,208,587
Avg Volume 6.74M
Rel Volume —
Perf Week -0.99%
Perf Month 4.52%
Perf Quarter -7.28%
Perf Half Y -4.71%
Perf YTD -5.72%
Perf Year 14.91%
Perf 3Y 57.41%
Perf 5Y 91.73%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $1.7300
TTM Yield 3.13%
TTM Amount $6.74
Payout Ratio 332.02%
3-Yr Growth (CAGR) 5.21%
5-Yr Growth (CAGR) 6.56%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $1.7300
Q1 2025 ~2025-12-31 $1.7300
Q3 2025 ~2025-09-30 $1.6400
Q2 2025 ~2025-06-30 $1.6400
Q1 2025 ~2025-03-31 $1.6400
Q1 2024 ~2024-12-31 $1.6400
Q1 2024 ~2024-09-30 $1.5500
Q1 2024 ~2024-06-30 $1.5500
Q1 2024 ~2024-03-31 $1.5500
Q4 2022 ~2022-12-09 $1.4800
Q3 2022 ~2022-09-09 $1.4100
Q2 2022 ~2022-06-23 $1.4100

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

AbbVie is a global, diversified research-based biopharmaceutical company with a mission to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. AbbVie is positioned for success with a comprehensive product portfolio that has leadership positions across immunology, neuroscience, oncology, and aesthetics. The company's products help patients and customers in more than 180 countries and territories around the world. Since inception, AbbVie has invested over $85 billion to research, develop, and discover new medicines and solutions. The company operates through multiple therapeutic segments and has a strong commitment to innovation, quality, compliance, safety, and performance. With approximately 57,000 employees worldwide driven by compassion for people, commitment to innovation and inclusion, and service to the community, AbbVie is focused on making a remarkable impact for patients, communities, and stakeholders.

Name
AbbVie Inc.
Industry
Drug Manufacturers - General
CEO
Robert A. Michael · Chairman of the Board and Chief Executive Officer
Employees
57,000 as of 2025-12-31
IPO Date
2017-03-02
Phone
(847) 932-7900
Address
1 North Waukegan Road, North Chicago, IL 60064
Website
www.abbvie.com

Key Executives

Name Title FY Pay
Azita Saleki-Gerhardt — —
Jeffrey R. Stewart — —
Roopal B. Thakkar — —
Scott T. Reents Chief Financial Officer —
Robert A. Michael Chairman of the Board and Chief Executive Officer —

Latest News